About: covid:PMC7072054

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7072054 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Towse, Adrian Postma, Maarten Christensen, Hannah Bloom, David Lorgelly, Paula Al-Janabi, Hareth Farkouh, Raymond Glennie, Linda Landa, Paolo Smith, Vinny Wright, Claire York, Laura Damm, Oliver Diez-Domingo, Javier Hernandez-Villafuerte, Karla Levy, Pierre Salisbury, David Shah, Koonal
is schema:about of	named entity 'Economic evaluation' named entity 'meningococcal vaccines' named entity 'serogroups' named entity 'disability' named entity 'QoL' named entity 'vaccine-preventable disease' named entity 'vaccine' named entity 'Netherlands' named entity 'serotype' named entity 'JCVI' named entity 'vaccine' named entity 'disease burden' named entity '1 million' named entity 'conjugate vaccines' named entity 'meningococcal vaccines' named entity 'vaccination' named entity 'vaccine' named entity 'nonspecific symptoms' named entity 'vaccine' named entity 'United Kingdom' named entity 'hearing loss' named entity 'Netherlands' named entity 'visual analogue scale' named entity 'epidemiology' named entity '16,000' named entity 'New Zealand' named entity 'human papilloma virus' named entity 'serogroup' named entity 'United Kingdom' named entity 'QoL' named entity 'serogroup' named entity 'economic evaluation' named entity 'public health' named entity 'QoL' named entity 'vaccination' named entity 'pneumococcal disease' named entity 'cost-effective' named entity 'QoL' named entity 'vaccine' named entity 'vaccine' named entity 'Economic Evaluation' named entity 'burden of disease' named entity 'EQ-5D' named entity 'cost-effective' named entity 'ICER' named entity 'vaccine' named entity 'serogroups' named entity 'sequelae' named entity 'nonspecific symptoms' named entity 'vaccine' named entity 'disability' named entity 'cost-effectiveness analysis' named entity 'morbidity' named entity 'Meningococcal vaccine' named entity 'vaccine' named entity '12/31' named entity 'vaccination' named entity 'cost-effectiveness' named entity 'QoL' named entity 'sequelae' named entity 'cost-effectiveness' named entity 'Japan' named entity 'vaccination' named entity 'septicemia' named entity 'MCDA' named entity 'JCVI' named entity 'Italy' named entity 'public health' named entity 'evaluation strategies' named entity 'nasopharynx' named entity 'long-term' named entity 'cost-effectiveness' named entity 'social welfare' named entity 'vaccine' named entity 'vaccine-preventable diseases' named entity 'cost-effectiveness' named entity 'disease burden' named entity 'cost-effectiveness' named entity 'cost-effectiveness' named entity 'long-term' named entity 'Australia' named entity 'cost-effective'

Attributes

Values

Creator

Towse, Adrian
Postma, Maarten
Christensen, Hannah
Bloom, David
Lorgelly, Paula
Al-Janabi, Hareth
Farkouh, Raymond
Glennie, Linda
Landa, Paolo
Smith, Vinny
Wright, Claire
York, Laura
Damm, Oliver
Diez-Domingo, Javier
Hernandez-Villafuerte, Karla
Levy, Pierre
Salisbury, David
Shah, Koonal

is schema:about of

named entity 'Economic evaluation'
named entity 'meningococcal vaccines'
named entity 'serogroups'
named entity 'disability'
named entity 'QoL'
named entity 'vaccine-preventable disease'
named entity 'vaccine'
named entity 'Netherlands'
named entity 'serotype'
named entity 'JCVI'
named entity 'vaccine'
named entity 'disease burden'
named entity '1 million'
named entity 'conjugate vaccines'
named entity 'meningococcal vaccines'
named entity 'vaccination'
named entity 'vaccine'
named entity 'nonspecific symptoms'
named entity 'vaccine'
named entity 'United Kingdom'
named entity 'hearing loss'
named entity 'Netherlands'
named entity 'visual analogue scale'
named entity 'epidemiology'
named entity '16,000'
named entity 'New Zealand'
named entity 'human papilloma virus'
named entity 'serogroup'
named entity 'United Kingdom'
named entity 'QoL'
named entity 'serogroup'
named entity 'economic evaluation'
named entity 'public health'
named entity 'QoL'
named entity 'vaccination'
named entity 'pneumococcal disease'
named entity 'cost-effective'
named entity 'QoL'
named entity 'vaccine'
named entity 'vaccine'
named entity 'Economic Evaluation'
named entity 'burden of disease'
named entity 'EQ-5D'
named entity 'cost-effective'
named entity 'ICER'
named entity 'vaccine'
named entity 'serogroups'
named entity 'sequelae'
named entity 'nonspecific symptoms'
named entity 'vaccine'
named entity 'disability'
named entity 'cost-effectiveness analysis'
named entity 'morbidity'
named entity 'Meningococcal vaccine'
named entity 'vaccine'
named entity '12/31'
named entity 'vaccination'
named entity 'cost-effectiveness'
named entity 'QoL'
named entity 'sequelae'
named entity 'cost-effectiveness'
named entity 'Japan'
named entity 'vaccination'
named entity 'septicemia'
named entity 'MCDA'
named entity 'JCVI'
named entity 'Italy'
named entity 'public health'
named entity 'evaluation strategies'
named entity 'nasopharynx'
named entity 'long-term'
named entity 'cost-effectiveness'
named entity 'social welfare'
named entity 'vaccine'
named entity 'vaccine-preventable diseases'
named entity 'cost-effectiveness'
named entity 'disease burden'
named entity 'cost-effectiveness'
named entity 'cost-effectiveness'
named entity 'long-term'
named entity 'Australia'
named entity 'cost-effective'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software